Need a specific person's email?
Browse Evaxion A/S's employee directory (about 51 employees) and reveal verified emails free.
Evaxion A/S's most common email format is Last@evaxion-biotech.com (ex. Doe@evaxion-biotech.com), used for 65% of evaxion-biotech.com addresses. Evaxion A/S uses 3 email patterns across 2 domains: evaxion-biotech.com and evaxion.ai. Percentages are the share of addresses within each domain.
| Format | Example | Share of evaxion-biotech.com |
|---|---|---|
| Last@evaxion-biotech.comMost common | Doe@evaxion-biotech.com | |
| FL@evaxion-biotech.com | JD@evaxion-biotech.com |
| Format | Example | Share of evaxion.ai |
|---|---|---|
| FL@evaxion.aiMost common | JD@evaxion.ai |
Browse Evaxion A/S's employee directory (about 51 employees) and reveal verified emails free.
Biotechnology ResearchHovedstaden, Denmark51-200 Employees
Evaxion A/S is a biotechnology research company based in Hørsholm, Denmark, focused on applying artificial intelligence to immunology. Its AI-Immunology platform is used to decode the human immune system in order to develop novel immunotherapies and vaccines for cancer, bacterial infections, and viral diseases, including personalized cancer vaccines and preclinical infectious disease programs. The company operates in a clinical-stage and preclinical space, targeting unmet medical needs by offering approaches that aim to design targeted treatments and vaccines. Its activities position it within the TechBio segment, combining computational methods with a focus on immune-related therapies. In addition to its core pipelines, Evaxion has engaged in collaborations and activities such as presenting AI-based vaccine design concepts and pursuing partnerships, including with the Gates Foundation, as part of its ongoing research and development efforts.
Most common format
Last@evaxion-biotech.com
Example: Doe@evaxion-biotech.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.